Nitric oxide and the proliferation of vascular smooth muscle cells.
about
Role of nitric oxide in heparin-induced attenuation of hypoxic pulmonary vascular remodeling.Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.The arterial microenvironment: the where and why of atherosclerosis.eNOS transfection of adipose-derived stem cells yields bioactive nitric oxide production and improved results in vascular tissue engineeringAMP-activated protein kinase activation as a strategy for protecting vascular endothelial function.The nitric oxide pathway and possible therapeutic options in pre-eclampsiaDimethylarginine metabolism during acute and chronic rejection of rat renal allograftsAndrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells.Modelling the effect of a functional endothelium on the development of in-stent restenosis.Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells.Interaction of G-protein beta3 subunit and nitric oxide synthase gene polymorphisms on carotid artery intima-media thickness in young adults: the Bogalusa Heart Study.Oxidation of LDL, atherogenesis, and apoptosis.The genetic basis for altered blood vessel function in disease: large artery stiffeningRecent developments in nitric oxide donor drugs.Asymmetric dimethylarginine plasma levels and endothelial function in newly diagnosed type 2 diabetic patientsReactive oxygen species and erectile dysfunction: possible role of NADPH oxidase.Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats.Statins as first-line therapy for acute coronary syndrome?Two N-(2-phenylethyl)nitroaniline derivatives as precursors for slow and sustained nitric oxide release agents.Thrombospondin-1: a physiological regulator of nitric oxide signalingCoronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaqueMicroRNAs as pharmacological targets in endothelial cell function and dysfunctionStatins in the first-line therapy of acute coronary syndrome - similar to aspirin?Molecular alterations associated with aneurysmal remodeling are localized in the high hemodynamic stress region of a created carotid bifurcation.The role of estrogen receptor subtypes for vascular maintenance.Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model.Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life.Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis.Effect of Nitric Oxide on the Expression of Matrix Metalloproteinase and Its Association with Migration of Cultured Trabecular Meshwork Cells.Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.Catheter-based high-frequency intraluminal ultrasound imaging is a powerful tool to study esophageal dysmotility patients.Effects of red wine on established markers of arterial structure and function in human studies: current knowledge and future research directions.Possible Reactions of Dietary Phenolic Compounds with Salivary Nitrite and Thiocyanate in the Stomach.Roles of Cells from the Arterial Vessel Wall in Atherosclerosis.Oxidative stress in hypertensive patients induces an increased contractility in vein grafts independent of endothelial function.Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivityNitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional coculturesAdjacent sequence controls the response polarity of nitric oxide-sensitive Sp factor binding sites.Superoxide from NADPH oxidase upregulates type 5 phosphodiesterase in human vascular smooth muscle cells: inhibition with iloprost and NONOate.Modulation of NO and ROS production by AdiNOS transduced vascular cells through supplementation with L-Arg and BH4: implications for gene therapy of restenosis.
P2860
Q30309237-B104C6F1-6E84-4914-822B-A441F233BCE7Q33593640-ED1463F1-452E-42BF-8719-9B33C082275EQ33619657-8E8E9BF4-EB9C-4F47-B8BD-85976025314AQ33728866-722258A1-535D-426B-BB0D-E6562F1D9BD1Q33848040-732D5152-6477-4B79-9C9E-329797DA5FF8Q34065261-776A232E-B31E-4D4B-A0F3-D18B64EBB283Q34426973-98EB4FD4-8EB1-4D38-BE07-14F965FECEEEQ34675805-ADD79046-5F1D-4E81-8CF2-55FE81A9B5F3Q34778866-A22D62D7-C944-498C-A638-530376E12DF4Q35049122-45FA4BE7-084F-403C-A93F-2984F063299DQ35144493-818CA807-16E1-4331-9922-EAFCECCA5D9AQ35700432-C0DB5F6D-691C-4765-8FAD-D6954C3C18F7Q36012883-B68E4719-DAEE-407C-9422-C2B4EE026226Q36052815-00C28D11-5515-4133-849D-358078E508E7Q36432385-66C8EE00-CBCA-4CCE-B022-C464C9F918D5Q36629849-18793FD4-5916-4E93-AC02-1FF012BFB697Q36682260-92D215F1-AA35-48FE-A83D-CB9AAD727568Q36768488-BDA97716-27C1-47FA-A63C-332AEF26BA41Q36871040-50B4EAF0-A6D9-48D7-A360-1601EC4D6234Q36926096-D51DBFB2-F49B-4709-9770-69EA6E9265B2Q37009785-E9E15C20-9BDD-4A39-B7DE-B2314FB97DBBQ37118124-1F4932DA-C9A4-47A0-AB9A-3D877EAC4915Q37276466-65C67BE3-426F-441E-A2C1-47129B7E20FFQ37367938-CB7AA8B0-A1C4-4165-8B83-9565B6367E3FQ37404662-1614D6FF-8F5E-4B18-99D3-5BE607306BB3Q38194032-2306BC10-56D1-42FE-9D53-768EBBBE19E2Q38213250-4A74FDA3-6620-4C5F-9588-338A817EFC6FQ38232998-753D6357-5A57-4EF3-88F7-D0D87B33A464Q38265027-6E1C58E6-4B59-4B28-9FA9-6C0408916133Q38698722-516AD463-21EA-41CE-877B-1BFB645EB7D0Q39111927-CA2E8226-935C-43D5-9B5B-147D6C62D878Q39325326-A3E7F8A3-8F55-4EE6-BB82-B38E08D6488EQ39415225-7EE02CDD-418C-4C8D-80F1-D78F96AEAAC6Q39416377-7B7784AD-5B63-4B1B-9291-CBC66B3807DDQ39489726-16DC0688-9CF4-4F98-91F0-D70A6B9DCFD3Q39516918-93FA8D25-4CB2-4FB0-A190-E4EFE2A2FE10Q39568242-F5F99CA8-A709-4FE2-B135-199B37B554E6Q40646180-A95391C8-6F1B-4704-8F6E-60800C3258EEQ41140201-696A63B3-BC48-41C7-B72A-2D8CF424D088Q41814727-43FEE093-E494-4C89-A971-151AC3E42F77
P2860
Nitric oxide and the proliferation of vascular smooth muscle cells.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Nitric oxide and the proliferation of vascular smooth muscle cells.
@ast
Nitric oxide and the proliferation of vascular smooth muscle cells.
@en
type
label
Nitric oxide and the proliferation of vascular smooth muscle cells.
@ast
Nitric oxide and the proliferation of vascular smooth muscle cells.
@en
prefLabel
Nitric oxide and the proliferation of vascular smooth muscle cells.
@ast
Nitric oxide and the proliferation of vascular smooth muscle cells.
@en
P2093
P1476
Nitric oxide and the proliferation of vascular smooth muscle cells.
@en
P2093
P304
P356
10.1016/S0008-6363(99)00171-6
P577
1999-08-01T00:00:00Z